INTRODUCTION
Embryonal carcinoma cells are the malignant stem cells of teratocarcinoma and resemble the pluripotent cells from the inner cell mass of early mouse preimplantation embryos (1, 2) . Undifferentiated EC cells are tumorigenic cells, that exhibit all the charasteristics of transformed cells. These include anchorage independent growth and proliferation in the absence of exogenous growth factors in vitro and tumorigenicity in vivo when transplanted to an extra-uterine site. EC cells have the capacity to differentiate in vitro in response to chemical agents, such as retinoic acid (3, 4) . Their differentiated derivatives are nontumorigenic cells that express growth factor receptors and require exogenous added growth factors for proliferation. The reversible nature of the transformed phenotype of EC cells suggests, that the tumorigeruc/growth factor independent growth state of EC cells and the non-tumorigenic/growth factor dependent growth state of their differentiated derivatives results from the onset of different genetic programs that can be modulated by RA Since RA is mediating its effects through the nuclear retinoic acid receptors (5, 6) , it is conceivable that characteristic changes in patterns of gene expression are responsible for this effect In order to obtain more insight in the molecular mechanisms underlying these different growth mechanisms, we have investigated the expression of the jun and fos genes and the involvement of their products in TRE dependent transcription during RA induced differentiation of EC cells. c-Jun is the cellular homolog of vjun, the transforming gene of avian sarcoma virus 17 (ASV 17) and encodes a major component of transcription factor API (7 -10) . The c-jun gene product binds to the TPA responsive element (TRE) enhancer sequence present in the promoter region of a variety of TPA responsive genes (8,11 -13) . Jun is capable of forming a heterodimeric protein complex with Fos, which exhibits increased affinity for DNA compared to the homodimeric Jun protein complex (14) (15) (16) (17) (18) (19) . This is caused by a greater syability of the Fos/Jun heterodimer compared to the Jun/Jun homodimer (68) . Site directed mutagenesis has indicated that the Fos-Jun protein complexes associate according to a parallel 'leucine zipper' (20) (21) (22) (23) (24) (25) (26) (27) . Both Fos and Jun are rapidly induced by growth factors in a variety of somatic cells and are post translationally modified by phosphorylation (28) (29) (30) (31) (32) (33) (34) . They are members of a larger family that includes the fos related antigen (fra-1), fos B, jun B and jun D genes (35) (36) (37) (38) . Fos-Jun complexes have been shown to be involved in both positive and negative transcriptional regulation of target genes containing the TRE/AP1 enhancer, including aP2, collagenase, transin, fos and c-jun itself (11, 12, (39) (40) (41) (42) (43) .
Previous investigations have shown, that F9 EC cells lack functional c-jun/ API activity, while transient transfection of the v/c-jun genes restores transcription from reporter constructs containing a TRE (10, 14, 15, 44, 45) . Differentiated derivatives of F9 cells express TRE binding proteins, which correlates with the TPA-induced expression of genes containing a TRE (46) . In * To whom correspondence should be addressed view of the different growth properties of EC cells versus their differentiated derivatives, we have investigated the differentiation dependent expression of TRE binding protein genes. Our results indicate that the c-jun, jun B and c-fos genes are differentially expressed and induced in both states of differentiation. Implications will be discussed in relation to the expression of target genes containing TRE enhancers involved in growth and differentiation of early embryonic cells.
METHODS

Cells and plasmids
P19 embryonal carcinoma cells and the differentiated clonal isolated cell lines EPI-7, Mes-1 and END-2 were cultured as described earlier (47, 48) . cDNA's of c-jun (W. Kruijer et al, unpublished) and jun B (37) were cloned into pSG5 (49) to generate plasmids for expression in eucaryotic cells. The plasmid pMT-fos was derived from pMGH (50) by replacing the XholBamHI GH specific fragment for the mouse c-fos Narl-BamHI (51). As probes for hybridization studies, a 1.0 kb PstI mouse c-jun genomic fragment, a 1.5 kb EcoRl cDNA fragment of jun B (37), a 1.7 kb EcoRI cDNA fragment of jun D (38), a 1.5 kb EcoRI cDNA fragment of fra-1 (35) and a 0.8 kb Pstl fragment of v-fos were used.
RNA isolation and northern blotting
Total cellular RNA was isolated by the guanidine isothiocyanate/caesium chloride method of Chirgwin et al. (52) . RNA was denatured for 10 min at 68°C in 50% (v/v) formamide, 2.2 M formaldehyde, 20 mM MOPS pH 7.0, 5 mM sodium acetate, 1 mM EDTA, separated through 0 8% agarose/2.2 M formaldehyde gels, and subsequently transferred to nitrocellulose filters (BA 85, Schleicher & Schuell) in 20x SSC. RNA was immobilized by baking at 80°C for 2 hr under vacuum. Hybridization was performed in 50% formamide, 5XSSC, 50 mM sodium phosphate pH 6.8, 10 mM EDTA, 0.1% NaDodS0 4 , 0.1 mg of sonicated salmon sperm DNA per ml, 2xDenhardt solution (lxDenhardt solution contains 0.02% bovine serum albumin, 0.02% ficoll, 0.02% polyvinylpyrrolidone) at 42°C overnight. 32 P-labeled probes were generated using a multipnme DNA labeling kit (Amersham). After hybridization and washing, filters were exposed to Kodak XAR-5 film at -70°C using intensifying screens.
Cell labeling and immunoprecipitation
Cell proteins were labeled for 45 min following a preincubation for 30 min in methionine-free medium by addition of L-[ 35 
S
] methionine (500 /tCi/ml, NEN) to subconfluent 3.5 cm dishes of P19 EC cells or P19 cells treated for 5 days with RA. The labeled cells were lyzed in 1 ml of RIPA buffer and protein was immunoprecipitated as described previously (28) . c-Jun protein was immunoprecipitated using anti-bp55 antiserum (15) . Fos/p39 complexes were immunoprecipitated with the anti-peptide M2 antiserum (53) .
DNA transfection and transient expression assays P19 cells were plated in DF-Bic/7.5% FCS at 4.10 5 per 50 mm tissue culture dish 24 hr prior to transfection, or in DF-Bic/7.5% FCS/10" 6 M retinoic acid at 2.10 5 cells per 50 mm tissue culture dish 72 hr prior to transfection. Two hours before transfection, the dishes recieved fresh medium. Cells were incubated for 20 hr with calcium phosphate precipitated DNA's (20/tg plasmid per 50 mm dish), followed by addition of fresh medium. Twenty four hours later, the cells were harvested followed by measuring CAT activity. 1 /tg of pSV2Apap was always included to serve as internal control to correct for possible variations in the transfection efficiency between different cell types. PAP assays were performed as described by Henthorn et al. (54) . CAT activity was determined as described by Gorman et al. (55) , and was quantitated by liquid scintillation counting of TLC plate 14 C spots.
Gel mobility shift assay An oligonucleotide containing the collagenase API binding site (11) was synthesyzed and cloned into pGEM plasmids (Promega). The sequence of the oligonucleotide (19-mer) was 5'GATCTATCTGAGTCAGCAG 3'. The ohgonucleotides were exscised from the plasmids by Sau3A and BamHI and isolated from a 10% (w/v) polyacrylamide gel. The cohesive ends of fragments were labeled with 32 PdATP and 32 PdCTP (5000 Ci/mol) using klenow fragment of DNA polymerase I. Labeled DNA fragments were separated from unincorporated nucleotides by gel filtration using Sephadex G-50 spin columns (Pharmacia) equilibrated in 10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 150 mM sodium chloride.
Isolation of nuclear extracts was performed by the mini-scale method described by Lee et al. (56) . Protein concentration was determined by the Biorad protein assay according to the manufacturers protocol.
The electrophoretic mobility shift assay (EMSA) used is based on the procedures described by Fried and Crothers (57) with slight modifications. Binding was earned out in 20 /xl of 10 mM TrisHCl (pH 7.5), 1 mM EDTA, 50 mM sodium chloride, 2 mM magnesium chloride, 10% (v/v) glycerol, 1 mM DTT, 0.1 mg/ml poly-(dI-dC), 10 ng/ml pUC8 plasmid DNA, 0.02% (v/v) nonidet P-40. 10 ng nuclear extract was incubated with 0.1 to 0.5 ng of 32 P-labeled DNA fragment at room temperature for 20 min. For some experiments, nuclear extracts were preincubated with a fifty fold excess of unlabeled competitor DNA in binding buffer for 10 min on ice. To stop the reaction, 4 /J of 0 2% bromophenolblue, 0.2% xylenexyanol-F, 25% ficoll was added, and the mixture was immediately loaded onto a 5% polyacrylamide gel containing 50 mM Tris-HCl (pH 8.5), 192 mM glycine, 1 mM EDTA. Electrophoresis was carried out at 2V/cm until the samples had entered the gel, and continued at 7V/cm for 3-4 hr. The gel was fixed in 10% methanol/ 10% (v/v) acetic acid for 20 min, dried, and visualized by autoradiography.
RESULTS
Differentiation dependent expression of TRE binding protein genes
Previously it has been shown, that nuclear extracts of F9 EC cells are devoid of proteins that bind to the consensus TRE/API enhancer sequence in vitro (10, 14, 15, 44, 45) . Differentiation of F9 EC cells by RA/dbcAMP results in expression of TRE binding activity and transcriptional activation of promoter-reporter DNA constructs containing the TRE enhancer (46) . Since these studies did not address the question, whether the absence of TRE binding activity in undifferentiated F9 EC cells resulted from lack of expression of TRE binding protein genes, we investigated their expression both in F9 as well as in P19 EC cells by Northern blotting. Undifferentiated P19 EC cells express very low levels of the c-jun gene (detectable on overexposed autoradiographs, data not shown), while treatment with RA for 24 to 48 hours, during which the cells become committed to form endoderm derivatives, results in a 10-20 fold increase in the steady state levels of cjun mRNA (Fig. 1) . A similar increase in c-jun mRNA was observed during differentiation of F9 cells (data not shown). Since P19 EC cells have a broader differentiation potential compared to F9 cells and express 10 times higher levels of phorbol ester receptors (see next section), this cell line was chosen for further investigation. As shown in Figure 1 , continued cultivation of P19 cells in the continuous presence of RA did not result in a further increase in steady state levels of c-jun mRNA. Both undifferentiated as well as differentiated derivatives of P19 cells express the c-jun gene as two transcripts of 2.7 and 3.4 kb. cjun mRNAs of similar size have been found in a variety of somatic cells (8, 30, 31) . In contrast to expression of c-jun, the jun B gene is neither expressed in undifferentiated P19 EC cells nor in its differentiated derivatives. Jun D, the third member of the jun gene family (38) , is expressed at constant levels during RA induced differentiation of P19 cells. Since the proteins of the Jun family are known to form heterodimers with the proteins from the Fos family, we investigated the expression of c-fos and the fos related antigen fra-1 during differentiation of P19 EC cells. As shown in figure 1, both these genes are not expressed in Differentiation dependent induction of c-jun, jun B and cfos Activation of protein kinase C by TPA results in transcriptional activation of a variety of genes, whose promoters contain a TRE/AP1 binding site (11, 58, 59) . Among the genes whose transcription is increased in response to TPA is c-jun itself, due to positive autoregulation by a TRE/AP1 binding site present in the promoter region of the c-jun gene (43) . Since c-jun is expressed at very low but detectable levels in P19 EC cells, the effect of TPA treatment on induction of the c-jun gene was investigated in P19 EC cells As shown in Figure 2 , addition of TPA to P19 EC cells did not result in induction of c-jun mRNA. In addition, jun B, jun D, c-fos and fra-1 expression was not induced by TPA. The inability to induce these genes by TPA is not trivial, as P19 EC cells express phorbol ester receptors (approximately 150.000 receptors/cell) and translocate protein kinase C from the cytoplasm to the plasma membrane in response to TPA (60) . In RA differentiated cells, TPA addition results in a relatively small (2-3 fold) increase in c-jun expression after 60 min. (Fig. 2) , despite gready elevated constitutive c-jun mRNA levels and expression of TRE binding proteins (see next section). Although the jun B and c-fos genes are not constitutively expressed in P19 EC cells treated for 5 days with RA (fig 1) , their expression is rapidly and transiently induced by TPA in diese cells. Maximal levels of induction are observed 30-60 min. after TPA addition, which return to prestimulation levels within 2 hours (c-fos) or 4-8 hours (jun B) (Fig. 2) . In contrast, TPA treatment of differentiated P19 cells did not result in an enhancement of jun D or fra-1 expression. These results show, diat unlike jun D and fra-1, the c-jun, jun B and c-fos genes are differentially induced by TPA in undifferentiated and differentiated P19 EC cells.
Expression of Jun and Fos proteins
To investigate whether the observed differential expression of fos and jun genes is accompanied by differential expression of Fos and Jun proteins, we lmmunoprecipitated proteins from y Smethionine pulse-labeled cells using anti-jun (bp55) and anti-fos (M2) antibodies. Undifferentiated and RA-differenuated P19 cells were treated for different periods widi TPA and lyzed in RIPA buffer to detect both free Jun and Jun-Fos heterodimers. As shown in figure 3 , neither Fos nor Jun proteins were immunoprecipitated from undifferentiated P19 EC cells. TPA treatment did not induce Fos or Jun expression in these cells. In RA-differentiated P19 cells however, Jun is constitutively expressed, while TPA treatment for 2 hours increased the abundance of immunoprecipitable Jun 2 -3 fold. Fos is not detected in untreated cells, but accumulates during TPA treatment for 2 hours. These results are in agreement with the increased c-jun mRNA levels following RA-induced differentiation of P19 EC cells (Fig. 1) , and the induction of c-jun and c-fos mRNA by TPA in RA-differentiated cells (Fig. 2) . S-methionine followed by lysis in RIPA buffer. Labeling was for 45 mm TPA (100 ng/rrJ) was added 15 min after (TPA 0 5 hr) or 75 mm before (TPA 2 hr) the 3i S methionine Immunoprccipitalion using anti-jun bp55, anti-fos M2 and non-immune serum (NIS) was performed as described in the methods section Autoradiography was for 5 days
Differentiation dependent expression of TRE binding proteins
The genes of the fos and jun families encode nuclear DNA binding proteins that bind to the TRE enhancer sequence in vitro (8, (17) (18) (19) . Since c-jun is differentially expressed during RA induced EC cell differentiation, the presence of TRE enhancer binding proteins in nuclear extracts of P19 EC and its differentiated derivatives was investigated using the electrophoretic mobility shift assay (EMSA). As probe a 32 Plabeled doubled stranded oligonucleotide containing the TRE/API enhancer sequence present in the promoter of the collagenase gene was used (11) . As shown in Figure 4A , nuclear extracts from undifferentiated P19 EC cells contain low levels of TRE binding activity, which are increased approximately 10 fold in cells treated for five days with RA. The TRE DNA-protein complex is resolved as a single broad band. The formation of this DNA-protein complex is inhibited by addition of a 50-fold molar excess of unlabeled competitor DNA containing the TRE/API binding site, but not by heterologous DNA sequences (pUC 18) lacking the recognition sequence (Fig. 4A) . The increase in TRE binding observed after RA induced differentiation of PI9 EC cells correlates with increased expression of the c-jun gene (Fig. 1) . Since jun B is not expressed after RA induced differentiation of P19 EC cells and jun D expression remains constant during the differentiation process, the increase in TRE binding activity is most likely due to increased expression of the c-jun gene. This is in agreement with the increase in p39/Jun after RA differentiation of P19 EC cells as detected by immunoprecipitation (Fig 3) .
The developmental expression of TRE/API binding proteins is not specific for P19 embryonal carcinoma cells, as a variety of mouse and human EC cell lines exhibit a differentiation dependent expression of TRE/API binding proteins. As shown by EMSA in Figure 4B , TRE/AP1 binding activity is low in nuclear extracts from undifferentiated P19, F9 and Tera 2 clone 13 EC cells, but present at greatly elevated levels in their differentiated derivatives obtained after RA treatment as well as in three clonal isolated differentiated cell lines of P19 EC resembling ectoderm (EPI-7), endoderm (END-2) and mesoderm (MES-1) (47, 48) . In the case of F9 cells, treatment with dbcAMP alone resulted in a small increase in TRE binding activity compared to the combined effects of RA and dbc AMP, suggesting that the increased TRE/API binding activity is RA and differentiation specific. In some experiments, an additional faster migrating DNA-protein complex was formed. The formation of this complex results from non-specific binding as it is not competed away with excess homologous competitor DNA (data not shown).
TPA differentially induces expression from a TRE reporter plasmid in P19 EC and its differentiated derivatives
In order to investigate, if the rise in TRE binding activity in P19 cells after RA induced differentiation is accompanied by transcriptional activation of the TRE enhancer, undifferentiated P19 cells and P19 cells treated for 5 days with retinoic acid were transfected with a TRE-tk-CAT reporter plasmid. As shown in Figure 5A , undifferentiated P19 have a low basal level of TRE dependent CAT activity, which is increased 8 fold following RA treatment for 5 days. A tk-CAT construct lacking the TRE enhancer is inactive both in undifferentiated as well as differentiated P19 cells, indicating that transcription from these constructs is TRE dependent. The increased TRE dependent CAT activity in differentiated cells correlates with the increased constitutive expression of the c-jun gene (Fig. 1) . In undifferentiated P19 EC cells, TPA treatment for 16 hours had no effect on TRE dependent CAT activity. TPA treatment of differentiated P19 cells resulted in a three fold increase in TRE dependent CAT activity as compared to unstimulated cells (Fig.  5A) . Although TPA is unable to increase TRE dependent CAT activity in undifferentiated P19 EC cells, TRE dependent CAT activity is increased by cotransfection with c-jun, jun B and cfos resulting in a 18, 13 and 13 fold increase, respectively. Combined expression of c-jun or jun B and c-fos has a synergistic effect leading to a 60 fold increase in TRE dependent CAT activity (Fig. 5B) . These results show, that in undifferentiated P19 EC cells TPA is unable to activate TRE dependent CAT activity. By contrast, in differentiated cells TPA addition results in an enhancement of TRE dependent CAT activity.
DISCUSSION
Expression of jun and fos genes during RA induced embryonal carcinoma cell differentiation
Differentiation of embryonal carcinoma cells in vitro is accompanied by major growth regulatory changes, including loss of anchorage independence and autonomous growth of the EC cells and acquisition of growth factor receptors and growth factor dependence of the differentiated derivatives (3, 4) . Differentiation of EC cells is therefore accompanied by major changes in the genetic programs specifying these different mechanisms of growth. To characterize these programs in more detail, we have investigated the differentiation dependent expression of the jun and fos genes, whose gene products encode DNA binding proteins that bind to the TRE enhancer (8) (9) (10) (11) (12) (13) 18) . These genes are induced by growth factors and agents capable of activation of components of the signal transduction cascade, thereby converting the response of extracellular stimuli into changes in gene expression (28) (29) (30) (31) (32) 37) .
Our results show, that c-jun is expressed at very low levels in undifferentiated EC cells, while its steady state mRNA levels are increased more then 20 fold within 48 hours of RA treatment, during which the cells become committed to differentiate. In contrast, the jun B gene is neither expressed in undifferentiated P19 EC cells nor in its RA differentiated derivatives. Jun D expression remains constant during RA induced differentiation. The presence of TRE binding proteins in nuclear extracts obtained from P19 EC cells and its RA differentiated derivatives correlates with increased expression of c-jun. At present in is unclear whether jun D is contributing to the observed TRE binding in undifferentiated P19 EC cells, as no tools are available to specifically identify its gene product. Both c-jun and jun B are induced by TPA in P19 RA differentiated cells, but not in undifferentiated P19 EC cells, indicating that these genes are responsive to activation of signal transduction only in constructs is TRE dependent. The increased TRE dependent CAT activity in differentiated cells correlates with the increased constitutive expression of the c-jun gene (Fig. 1) . In undifferentiated P19 EC cells, TPA treatment for 16 hours had no effect on TRE dependent CAT activity. TPA treatment of differentiated P19 cells resulted in a three fold increase in TRE dependent CAT activity as compared to unstimulated cells (Fig.  5A) . Although TPA is unable to increase TRE dependent CAT activity in undifferentiated P19 EC cells, TRE dependent CAT activity is increased by cotransfection with c-jun, jun B and cfos resulting in a 18, 13 and 13 fold increase, respectively. Combined expression of c-jun or jun B and c-fos has a synergistic effect leading to a 60 fold increase in TRE dependent CAT activity (Fig. 5B) . These results show, that in undifferentiated P19 EC cells TPA is unable to activate TRE dependent CAT activity. By contrast, in differentiated cells TPA addition results in an enhancement of TRE dependent CAT activity.
DISCUSSION
Expression of jun and fos genes during RA induced embryonal carcinoma cell differentiation
Our results show, that c-jun is expressed at very low levels in undifferentiated EC cells, while its steady state mRNA levels are increased more then 20 fold within 48 hours of RA treatment, during which the cells become committed to differentiate. In contrast, the jun B gene is neither expressed in undifferentiated P19 EC cells nor in its RA differentiated derivatives. Jun D expression remains constant during RA induced differentiation. The presence of TRE binding proteins in nuclear extracts obtained from P19 EC cells and its RA differentiated derivatives correlates with increased expression of c-jun. At present in is unclear whether jun D is contributing to the observed TRE binding in undifferentiated P19 EC cells, as no tools are available to specifically identify its gene product. Both c-jun and jun B are induced by TPA in P19 RA differentiated cells, but not in undifferentiated P19 EC cells, indicating that these genes are responsive to activation of signal transduction only in differentiated cells. At present it is unclear whether c-jun, previously shown to contain TRE, CAAT and SP1 sequences as regulatory elements (61) , is a direct target for regulation by the retinoic acid receptors during EC cell differentiation. Neither is it presently clear, which factor(s) is (are) involved in the inducibility of jun B and c-fos by TPA in differentiated derivatives of P19 cells. Recent studies in P19 cells stably transfected with c-jun however suggest that the presence of c-jun protein is sufficient for jun B, but not for c-fos, to be induced by TPA, indicating that these genes are induced by TPA via different mechanisms (62) .
TRE dependent transcription in P19 cells and its differentiated derivatives
Since TRE binding proteins are differentially expressed during EC cell differentiation, we examined TRE dependent activation of a CAT reporter construct, both in undifferentiated P19 EC as well as in its RA differentiated derivatives. Despite low levels of TRE binding activity in undifferentiated P19 EC cells, no TRE dependent expression of a TRE-tk-CAT reporter constuct was observed. Similar results were obtained following transfection of a TRE-tk-CAT reporter plasmid in undifferentiated F9 cells, supporting our view that undifferentiated EC cells are deficient in expression of TRE binding proteins ( Fig. 4 ; ref. 10, 14, 44, 45) . This also implies, that jun D, which is constitutively expressed in undifferentiated F9 and P19 cells, is either low in abundance, or inefficient in TRE trans-activation in the absence of Fos as was previously suggested (63) . In RA differentiated P19 cells, expressing elevated levels of TRE binding proteins, an enhanced basal level of TRE dependent CAT activity is present. In these cells, TRE dependent CAT activity can be further increased in response to TPA, while no increase in TRE dependent CAT expression by TPA is observed in undifferentiated P19 EC cells. The functionality of the TPA activated PKC signal transduction pathway in P19 EC cells is however demonstrated by the translocation of PKC to the plasma-membrane upon TPA treatment (60) . Activation of TRE dependent CAT activity in response to TPA correlates with the differential induction of the c-jun, jun B and c-fos genes in both cell types. In this respect, c-jun can be regarded as a target gene due to the presence of a TRE/API binding site in the c-jun promoter (61) . Cotransfection of c-fos, c-jun and jun B strongly enhances TREdependent transcription in P19 EC cells, suggesting that the inability of TPA to induce TRE-dependent transcription in undifferentiated P19 cells may result from the mere absence of these proteins in these cells.
Developmental regulation of target genes containing a TRE enhancer
A number of genes encoding growth regulatory molecules affecting proliferation and differentiation of early embryonic cells have been shown to posess a TRE enhancer. These include TGF/31, which in combination with fibroblast growth factor (FGF) is capable of mesoderm induction in Xenopus laevis tissue explants (67) , PDGFII and the metalloproteases collagenase and stomelysin/transin I, which are involved in extracellular matrix degradation (64) (65) (66) . The differential expression of TRE binding proteins during EC cell differentiation is therefore likely linked to the regulation of these genes both during EC cell differentiation as well as during early mammalian development. Moreover, ectopic expression of c-jun in P19 EC cells lead to differentiation and loss of the transformed phenotype of these cells, further
